RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats-Reference-Cited by-同舟云学术

RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats

Published:2017-09 Issue: Volume:810 Page:92-99
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bhat Laxminarayan,Hawkinson Jon,Cantillon Marc,Reddy Dasharatha G.,Bhat Seema R.,Laurent Charles E.,Bouchard Annie,Biernat Marzena,Salvail Dany

Funder

Reviva Pharmaceuticals., Inc

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. Serotonin in antipsychotic drugs action;Amato;Behav. Brain Res.,2015

2. Sildenafil in the treatment of pulmonary hypertension;Barnett;Vasc. Health Risk Manag.,2006

3. A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics;Baou;Schizophr. Res.,2016

4. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry;Benza;Chest,2012

5. Dopamineserotonin stabilizer RP5063: A randomized, double-blind, placebo-controlledmulticenter trial of safety and efficacy in exacerbation of schizophrenia orschizoaffective disorder;Cantillon;Schizophr. Res.,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brilaroxazine lipogel displays antipsoriatic activity in imiquimod‐induced mouse model;Skin Research and Technology;2024-02

2. Targeting erythrocyte-mediated hypoxia to alleviate lung injury induced by pyrrolizidine alkaloids;Archives of Toxicology;2023-01-13

3. Investigation of Genes and Proteins Expression Associating Serotonin Signaling Pathway in Lung and Pulmonary Artery Tissues of Dogs with Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease: The Preliminary Study;Veterinary Sciences;2022-09-28

4. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho;Comprehensive Physiology;2022-08-29

5. SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension;AAPS PharmSciTech;2022-06-08